Genpact (G)
(Delayed Data from NYSE)
$30.69 USD
-1.07 (-3.37%)
Updated Apr 25, 2024 04:00 PM ET
After-Market: $30.67 -0.02 (-0.07%) 7:58 PM ET
4-Sell of 5 4
A Value B Growth D Momentum B VGM
Income Statements
Fiscal Year end for Genpact Limited falls in the month of December .
All items in Millions except EPS data.
12/31/23 | 12/31/22 | 12/31/21 | 12/31/20 | 12/31/19 | |
---|---|---|---|---|---|
Sales | 4,477 | 4,371 | 4,022 | 3,709 | 3,521 |
Cost Of Goods | 2,906 | 2,835 | 2,590 | 2,418 | 2,295 |
Gross Profit | 1,571 | 1,536 | 1,432 | 1,291 | 1,226 |
Selling & Adminstrative & Depr. & Amort Expenses | 940 | 1,034 | 923 | 853 | 796 |
Income After Depreciation & Amortization | 631 | 502 | 509 | 439 | 429 |
Non-Operating Income | -29 | -37 | -26 | -38 | -30 |
Interest Expense | 0 | 0 | 0 | 0 | 0 |
Pretax Income | 602 | 465 | 483 | 400 | 399 |
Income Taxes | -29 | 112 | 114 | 92 | 95 |
Minority Interest | 0 | 0 | 0 | 0 | 0 |
Investment Gains/Losses | 0 | 0 | 0 | 0 | 0 |
Other Income/Charges | 0 | 0 | 0 | 0 | 0 |
Income From Cont. Operations | 631 | 353 | 369 | 308 | 305 |
Extras & Discontinued Operations | 0 | 0 | 0 | 0 | 0 |
Net Income (GAAP) | 631 | 353 | 369 | 308 | 305 |
Depreciation Footnote | 12/31/23 | 12/31/22 | 12/31/21 | 12/31/20 | 12/31/19 |
---|---|---|---|---|---|
Income Before Depreciation & Amortization | 737 | 634 | 679 | 601 | 560 |
Depreciation & Amortization (Cash Flow) | 106 | 132 | 170 | 162 | 130 |
Income After Depreciation & Amortization | 631 | 502 | 509 | 439 | 429 |
Earnings Per Share Data | 12/31/23 | 12/31/22 | 12/31/21 | 12/31/20 | 12/31/19 |
---|---|---|---|---|---|
Average Shares | 185.14 | 188.09 | 192.96 | 195.78 | 195.16 |
Diluted EPS Before Non-Recurring Items | 2.50 | 2.45 | 2.13 | 1.85 | 1.56 |
Diluted Net EPS (GAAP) | 3.41 | 1.88 | 1.91 | 1.57 | 1.56 |
Fiscal Year end for Genpact Limited falls in the month of December .
All items in Millions except EPS data.
3/31/24 | 12/31/23 | 9/30/23 | 6/30/23 | 3/31/23 | |
---|---|---|---|---|---|
Sales | NA | 1,146.25 | 1,135.79 | 1,105.52 | 1,089.32 |
Cost Of Goods | NA | 738.70 | 732.96 | 715.48 | 719.08 |
Gross Profit | NA | 407.55 | 402.83 | 390.04 | 370.24 |
SG&A, R&D, and Dept/Amort Expenses | 0.00 | 244.82 | 237.14 | 232.72 | 225.13 |
Income After SG&A, R&D, and Dept/Amort Expenses | 0.00 | 162.73 | 165.69 | 157.32 | 145.11 |
Non-Operating Income | NA | -4.26 | -10.79 | -6.95 | -6.64 |
Interest Expense | NA | 0.00 | 0.00 | 0.00 | 0.00 |
Pretax Income | NA | 158.47 | 154.91 | 150.37 | 138.48 |
Income Taxes | NA | -132.84 | 37.31 | 34.12 | 32.37 |
Minority Interest | NA | 0.00 | 0.00 | 0.00 | 0.00 |
Investment Gains/Losses | NA | 0.00 | 0.00 | 0.00 | 0.00 |
Other Income/Charges | NA | 0.00 | 0.00 | 0.00 | 0.00 |
Income From Cont. Operations | NA | 291.31 | 117.59 | 116.25 | 106.10 |
Extras & Discontinued Operations | NA | 0.00 | 0.00 | 0.00 | 0.00 |
Net Income (GAAP) | NA | 291.31 | 117.59 | 116.25 | 106.10 |
Earnings Per Share Data | 3/31/24 | 12/31/23 | 9/30/23 | 6/30/23 | 3/31/23 |
---|---|---|---|---|---|
Average Shares | NA | 183.35 | 183.80 | 185.83 | 187.59 |
Diluted EPS Before Non-Recurring Items | NA | 0.68 | 0.67 | 0.60 | 0.60 |
Diluted Net EPS (GAAP) | NA | 1.57 | 0.64 | 0.63 | 0.57 |